Department of Pathology, Stanford University, Stanford, CA 94305.
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305.
Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):6470-6475. doi: 10.1073/pnas.1720273115. Epub 2018 Jun 4.
Human cell models for disease based on induced pluripotent stem (iPS) cells have proven to be powerful new assets for investigating disease mechanisms. New insights have been obtained studying single mutations using isogenic controls generated by gene targeting. Modeling complex, multigenetic traits using patient-derived iPS cells is much more challenging due to line-to-line variability and technical limitations of scaling to dozens or more patients. Induced neuronal (iN) cells reprogrammed directly from dermal fibroblasts or urinary epithelia could be obtained from many donors, but such donor cells are heterogeneous, show interindividual variability, and must be extensively expanded, which can introduce random mutations. Moreover, derivation of dermal fibroblasts requires invasive biopsies. Here we show that human adult peripheral blood mononuclear cells, as well as defined purified T lymphocytes, can be directly converted into fully functional iN cells, demonstrating that terminally differentiated human cells can be efficiently transdifferentiated into a distantly related lineage. T cell-derived iN cells, generated by nonintegrating gene delivery, showed stereotypical neuronal morphologies and expressed multiple pan-neuronal markers, fired action potentials, and were able to form functional synapses. These cells were stable in the absence of exogenous reprogramming factors. Small molecule addition and optimized culture systems have yielded conversion efficiencies of up to 6.2%, resulting in the generation of >50,000 iN cells from 1 mL of peripheral blood in a single step without the need for initial expansion. Thus, our method allows the generation of sufficient neurons for experimental interrogation from a defined, homogeneous, and readily accessible donor cell population.
基于诱导多能干细胞(iPS)的人类疾病细胞模型已被证明是研究疾病机制的强大新工具。通过基因靶向生成同基因对照,研究单一突变获得了新的见解。由于个体间的变异性和扩展到数十个或更多患者的技术限制,使用患者来源的 iPS 细胞对复杂的多基因特征进行建模要困难得多。可以从许多供体中获得直接从真皮成纤维细胞或尿上皮细胞重编程的诱导神经元(iN)细胞,但这种供体细胞是异质的,表现出个体间的变异性,并且必须进行广泛的扩增,这可能会引入随机突变。此外,真皮成纤维细胞的衍生需要侵入性活检。在这里,我们展示了人类成年外周血单核细胞以及定义明确的纯化 T 淋巴细胞可以直接转化为完全功能的 iN 细胞,证明终末分化的人类细胞可以有效地转分化为远缘谱系。通过非整合基因传递生成的 T 细胞衍生的 iN 细胞表现出典型的神经元形态,并表达多种泛神经元标志物,可发出动作电位并形成功能性突触。在没有外源性重编程因子的情况下,这些细胞是稳定的。小分子添加和优化的培养系统可使转化率高达 6.2%,从而可以从 1 毫升外周血中在单个步骤中生成超过 50,000 个 iN 细胞,而无需初始扩增。因此,我们的方法允许从定义明确、同质且易于获得的供体细胞群中生成足够数量的神经元进行实验研究。